Established criteria for disease controlling drugs in ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 62, Issue 9, 2003, Pages 793-794

  Gladman, D D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; AZATHIOPRINE; CORTICOSTEROID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE;

ANALGESIA; ANKYLOSING SPONDYLITIS; ARTHRITIS; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; EDITORIAL; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; INFLAMMATION; LOW BACK PAIN; SPINE MALFORMATION; TREATMENT PLANNING;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041885154     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.9.793     Document Type: Editorial

References (20)

1. Gladman DD. Clinical aspects of spondyloarthropathies. Am J Med Sci 1998;316:234-8.
2. Gran JT. An epidemiologic survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol 1985;4:161-9.
3. Resnick D, Niyawama C. Ankylosing spondylitis. In: Resnick D, ed. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: Saunders, 1994:1008-74.
4. Cohen MD, Ginsurg WW. Late onset peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
5. Carrett S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course af ankylosing spondylitis. Arthritis Rheum 1993;26:186-90.
6. Resnick D. Radiology of seronegative spondyloarthropathies. Clin Orthop Relat Res 1979;143:38-45.
7. O'Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis 1992;51:705-6.
8. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith CH. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis - an 8-month followup. J Rheumatol 1994;21:261-3.
9. Dagfinrud H, Hagen K. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2001;4:CD002822.
10. Miceli-Richard C, Dougados M. NSAIDs in ankylosing spondylitis. Clin Exp Rheumatol 2002; 20(suppl 28):S65-6.
11. Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 1990;17:1482-6.
12. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. Arthritis Rheum 1996;39:2004-12.
13. Maksyrnowych W, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, et al. Canadian Rheumatology Association consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of SpA. J Rheumatol 2003;30:1356-63.
14. Van den Bosch F, Kruithof E, Baeten D, Herssens A, De Keyser F, Mielants H, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum 2002;46:755-65.
15. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002;359:1187-93.
16. Stone M, Salonen D, Lax M, Payne U, Lapp V, Inman R. Clinical and imaging correrates of response to treatment with infliximab in patients with ankylosing spondylitis. J Rheumatol 2001;28:1605-14.
17. Davis JC, van der Heijde D, Braun J, Dougados M, Cush JJ, Clegg DO, et al. Etanercept (Enbrel) improves signs and symptoms of ankylosing spondylitis: results of a phase 3 multicentre clinical trial [abstract]. Ann Rheum Dis 2003;62(suppl 1):65.
18. Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J. Biologic therapies in the spondyloarthritis: new opportunities, new challenges. Curr Opin Rheumatol 2003;15:394-407.
19. Braun J, Pham T, Sieper J, Davis J, van der Linden Sj, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
20. Pham T, van der Heijde D, Calin A, Kham MA, van der Linden Sj, Bellamy N, et al. Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis 2003;62:ar022873.